Intranasally applicable powdery pharmaceutical composition

Details Intranasally applicable powdery pharmaceutical composition Intranasally applicable powdery pharmaceutical composition

1987-12-14

1991-01-15

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

424 858, 514 2, 514 3, 514 11, 514 12, A61K 3766, A61K 3900, A61K 3700, A61K 3726

Patent

active

049852426

ABSTRACT:
An intranasally applicable powdery pharmaceutical composition comprising a polypeptide having a physiological activity, a quaternary ammonium compound, and a lower alkyl ether of cellulose. This powdery pharmaceutical composition has an excellent preservability and chemical stability of the polypeptides and, when the powdery composition is administered to the nasal cavity in the form of a spray, the polypeptides are effectively absorbed through the nasal mucosa.

REFERENCES:
patent: 4613500 (1986-09-01), Suzuki et al.
S. Hirai et al, Diabetes vol. 27, p. 296, (1978).

Affiliated with

Also associated with

Rating

Intranasally applicable powdery pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intranasally applicable powdery pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intranasally applicable powdery pharmaceutical composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-54322